Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Alzamend Neuro, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −1 vs. Q1 2022
- Shares held
- 3.09M
- −165.2K (−5.1%) vs. Q1 2022
- Total value
- $2.70M
- −$1.31M (−32.7%) vs. Q1 2022
- New holders
- 6
- 5 more added
- Sold out
- 7
- 4 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $3.26M |
| Q1 2026 | 13 | $723.1K |
| Q4 2025 | 13 | $447.2K |
| Q3 2025 | 11 | $351.3K |
| Q2 2025 | 7 | $6.36K |
| Q1 2025 | 11 | $59.9K |
| Q4 2024 | 17 | $131.7K |
| Q3 2024 | 12 | $71.2K |
| Q2 2024 | 16 | $150.5K |
| Q1 2024 | 13 | $386.8K |
| Q4 2023 | 16 | $334.7K |
| Q3 2023 | 27 | $1.49M |
| Q2 2023 | 24 | $3.13M |
| Q1 2023 | 26 | $2.64M |
| Q4 2022 | 33 | $3.98M |
| Q3 2022 | 17 | $9.41M |
| Q2 2022 | 21 | $2.70M |
| Q1 2022 | 22 | $4.01M |
| Q4 2021 | 20 | $1.66M |
| Q3 2021 | 17 | $1.99M |
| Q2 2021 | 11 | $2.58M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Alzamend Neuro, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Truist Financial Corp | 2,314,907 | $2.00M | 0.00% | 00.0% | Unchanged |
| RFG Advisory, LLC | 250,000 | $240.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 101,646 | $88.0K | 0.00% | +101,646 | New |
| Susquehanna International Group, LLP | 83,950 | $73.0K | 0.00% | +25,985+44.8% | Added |
| Renaissance Technologies LLC | 65,131 | $56.0K | 0.00% | +65,131 | New |
| Vanguard Group Inc | 60,747 | $53.0K | 0.00% | +60,747 | New |
| Millennium Management LLC | 49,223 | $43.0K | 0.00% | −93,163−65.4% | Reduced |
| Geode Capital Management, LLC | 40,587 | $35.0K | 0.00% | 00.0% | Unchanged |
| Kingsbury Capital Investment Advisors LLC | 25,059 | $22.0K | 0.03% | +13,540+117.5% | Added |
| UBS Group AG | 20,282 | $18.0K | 0.00% | +4,206+26.2% | Added |
| Commonwealth Equity Services, LLC | 16,666 | $14.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 15,458 | $13.0K | 0.00% | −18,300−54.2% | Reduced |
| Tower Research Capital LLC (TRC) | 15,266 | $13.0K | 0.00% | +3,017+24.6% | Added |
| Group One Trading, L.P. | 11,702 | $10.0K | 0.00% | +11,702 | New |
| Insight Wealth Strategies, LLC | 10,000 | $9.00K | 0.00% | +10,000 | New |
| Morgan Stanley | 3,900 | $3.00K | 0.00% | +100+2.6% | Added |
| Simplex Trading, LLC | 2,701 | $2.00K | 0.00% | −31,985−92.2% | Reduced |
| Citigroup Inc | 2,000 | $2.00K | 0.00% | +2,000 | New |
| Bank of America Corp | 1,692 | $1.00K | 0.00% | −26,505−94.0% | Reduced |
| Harbor Investment Advisory, LLC | 1,715 | $1.00K | 0.00% | 00.0% | Unchanged |
| Money Concepts Capital Corp | 250 | $0 | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −124,115−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −78,465−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −37,900−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −19,601−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −16,628−100.0% | Sold out |
| Forum Private Client Group LLC | 0 | $0 | 0.00% | −16,302−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −300−100.0% | Sold out |